Tīmeklis2024. gada 11. maijs · EPZM initiated a phase Ib/II basket study, ARIA (EZH-1501), during fourth-quarter 2024 to evaluate the safety and efficacy of tazemetostat across multiple new types of hematological malignancies. Tīmeklis2024. gada 10. janv. · EZH-1301 (Solid Tumor) and EZH-1501 (Hematological) Basket Studies: The Company recently opened sites for these two basket studies, which sites are actively screening patients for enrollment in each of the studies. Epizyme plans to provide updates as the studies reach key enrollment milestones, as well as …
Модуль:Statistical/RUS-KHA — Википедия
Tīmeklis2015. gada 11. nov. · EZH-102 : First Posted: November 11, 2015 Key Record Dates: Last Update Posted: December 27, 2024 Last Verified: December 2024 Additional … Tīmeklis2024. gada 1. marts · Initiated Phase 1b/2 tazemetostat hematological basket study (EZH-1501): During the fourth quarter of 2024, Epizyme initiated EZH-1501, its … our home doggy daycare \\u0026 boarding
Epizyme (EPZM) Q4 Loss Wider Than Expected, Revenues Lag
Tīmeklis2024. gada 10. janv. · EZH-1301 (Solid Tumor) and EZH-1501 (Hematological) Basket Studies: The Company recently opened sites for these two basket studies, which … Tīmeklisstudy (aria, ezh-1501) ezm0414 set-101 study in r/r mm and dlbcl. by the numbers. tazverik total . net revenue . $8.7m . total commercial demand . increased 16%. from 4q21. cash position. $199.7m. total operating expenses . $59.6m. marketplace highlights. tazverik now a suggested treatment option in 2l for elderly/infirm patients … Tīmeklis2024. gada 2. marts · The company has entered into a clinical supply agreement with Roche for the bispecific cohort of the EZH-1501 study.Our TakeEpizyme’s … our home coffee table